Peirce Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Peirce Capital Management's LLY Position: Q2 2026 in Review
Peirce Capital Management increased its Eli Lilly (LLY) stake by 6.9% in Q2 2026, buying an estimated $26.6K and bringing the position to 403 shares worth $483K. The position accounts for 0.18% of the portfolio, ranked #35.
Peirce Capital Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Peirce Capital Management held 403 shares of Eli Lilly worth $483K as of Q2 2026.
- Peirce Capital Management bought 26 Eli Lilly shares in Q2 2026, an estimated $26.6K.
- Eli Lilly made up 0.18% of Peirce Capital Management's portfolio in Q2 2026, its #35 holding.
- Peirce Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Peirce Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.